SCHEMBL2808315

SCHEMBL2808315

CCOc1ccc(Nc2ccc(CNC(=O)C3(N)CC3)cc2)c(C(F)(F)F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 4/20 0.39
KDM4E B2RXH2 2/20 0.39
AKT2 P31751 2/20 0.39
EPHX2 P34913 1/20 0.38
NR1H4 Q96RI1 1/20 0.38
MEN1 O00255 3/20 0.38
KLKB1 P03952 1/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
S1PR1 P21453 1/20 0.38
S1PR3 Q99500 1/20 0.38
PAX8 Q06710 1/20 0.37
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
NAMPT P43490 2/20 0.36
ALPL P05186 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2778630 0.89 NPC1 (0.40) NPC1RAB9AKMT2AKDM4EEPHX2
SCHEMBL2809872 0.88 TP53 (0.40) NPC1RAB9AAKT2EPHX2NR1H4
Hydrochloric Acid SCHEMBL2805730 0.88 AKT2 (0.38) AKT2EPHX2S1PR1S1PR3BTK
SCHEMBL185133 0.83 CNR2 (0.41) NPC1RAB9AKDM4EAKT2ALDH1A1
SCHEMBL13128516 0.80 BDKRB1 (0.48) NPC1RAB9AEPHX2NR1H4LMNA
SCHEMBL184945 0.80 MT-CO2 (0.43) NPC1RAB9AKMT2AKDM4EAKT2
SCHEMBL185836 0.79 KLKB1 (0.46) KMT2AKDM4EMEN1KLKB1LMNA
SCHEMBL13160176 0.78 BTK (0.33) NPC1RAB9AKMT2AKDM4EMEN1
SCHEMBL2779286 0.77 PTGES (0.34) S1PR1S1PR3BTK
SCHEMBL2809865 0.77 TP53 (0.39) NPC1RAB9AEPHX2NR1H4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130131075-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-05-23 US disclosed
US-20100240669-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131075-A1 NEW COMPOUNDS ADORA1, H1-10, P2RY11 NPC1 926/4885RAB9A 347/4885KMT2A 4682/4885
US-20100240669-A1 NEW COMPOUNDS ADORA1, H1-10, P2RY11 NPC1 926/4885RAB9A 347/4885KMT2A 4682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.